Changes in the management of patients with acute coronary syndrome – have the disease outcomes changed?

Aim        To analyze results of changing the management tactics in patients with acute coronary syndrome (ACS) in clinical practice from 2004 through 2018 expressed as improvement in prognosis.

Material and methods        Results of two observational studies were analyzed: ORACLE I (2004–2007), which included 1193 patients with ACS (mean age, 61.1±11.69 years; men, 63.3 %) and ORACLE II (2014–2017), which included 1652 patients from 4 vascular centers (mean age, 64.61±12.67 years; men, 62.3 %).

Results   Patients included into the ORACLE II study in 2014 were significantly older and the proportion of patients with diabetes mellitus was greater than in the ORACLE I study (14.7 and 22.6 %, respectively). After matching the groups by major clinical characteristics, it was found that introducing the invasive management tactics for ACS patients was associated with a reduced rate of all-cause death (from 8.2 to 6.1 % for one year), a tendency towards decreased number of coronary death cases (from 5.6 to 4.0 %), and a decrease in risk of recurrent coronary complications (from 17.4  to 7.7 %).

Conclusion            Implementing the vascular program statistically significantly decreased the total death rate for at least one-year observation in comparable patient groups.

1. Zateyshchikov D.A., Volkova E.G., Guz I.O., Evdokimova M.A., Aseycheva O.Yu., Galyavich A.S. et al. Treatment of patients who underwent acute coronary syndrome, according to the Russian multicenter prospective observational study. Pharmateca. 2009;12 (186):109- 13.

2. Averkova A.O., Brazhnik V.A., Koroleva O.S., Zubova E.A., Hasanov N.R., Chichkov Yu.M. et al. Acute coronary syndrome in young patients with familial hyperchoolesterolemia based on the results of Oracul II observation trial. Medical news of the North Caucasus. 2017;12 (1):5-8. https://doi.org/10.14300/mnnc.2017.12001

3. Ge Z, Baber U, Claessen BE, Farhan S, Chandrasekhar J, Li SX et al. The prevalence, predictors and outcomes of guideline-directed medical therapy in patients with acute myocardial infarction undergoing PCI, an analysis from the PROMETHEUS registry. Catheterization and Cardiovascular Interventions. 2019;93 (3):E112-9. https://doi.org/10.1002/ccd.27860

4. Choe JC, Cha KS, Ahn J, Park JS, Lee HW, Oh J-H et al. Comparison of prescription rates and clinical outcomes in acute coronary syndrome patients who underwent percutaneous coronary intervention using different P2Y12 inhibitors in a large observational study. International Journal of Cardiology. 2019;274:21-6. https://doi.org/10.1016/j.ijcard.2018.09.011

5. Biswas S, Andrianopoulos N, Papapostolou S, Noaman S, Duffy SJ, Lefkovits J et al. Does the subtype of acute coronary syndrome treated by percutaneous coronary intervention predict long-term clinical outcomes? European Heart Journal - Quality of Care and Clinical Outcomes. 2018;4 (4):318-27. https://doi.org/10.1093/ehjqcco/qcy009

6. Cirillo P, Di Serafino L, Patti G, Antonucci E, Calabrò P, Gresele P et al. Gender-Related Differences in Antiplatelet Therapy and Impact on 1-Year Clinical Outcome in Patients Presenting With ACS: The START ANTIPLATELET Registry. Angiology. 2019;70 (3):257-63. https://doi.org/10.1177/0003319718783866

7. D’Ascenzo F, Celentani D, Brustio A, Grosso A, RaposeirasRoubín S, Abu-Assi E et al. Association of Beta-Blockers with Survival on Patients Presenting with ACS Treated with PCI: A Propensity Score Analysis from the BleeMACS Registry. American Journal of Cardiovascular Drugs. 2018;18 (4):299-309. https://doi.org/10.1007/s40256-018-0273-4

8. Erlikh A.D. Twelve months outcomes in patients with acute coronary syndrome, by the national registry RECORD-3. Russian Journal of Cardiology. 2018;23 (3):23-30. [Russian: Erlikh A.D. 12-mesyachnye iskhody u patsientov s ostrym koronarnym sindromom, vklyuchennykh v rossiiskii registr «REKORD-3». Rossiiskii kardiologicheskii zhurnal. 2018;23 (3):23-30]. https://doi.org/10.15829/1560-4071-2018-3-23-30

9. Hamilos M, Petousis S, Xanthopoulou I, Goudevenos J, Kanakakis J, Sitafidis G et al. Antiplatelet treatment in diabetic patients with acute coronary syndrome undergoing percutaneous coronary intervention: a GReek AntiPlatElet registry substudy. Coronary Artery Disease. 2018;29 (1):53-9. https://doi.org/10.1097/MCA.0000000000000547

10. Panduranga P, Al-Rashidi M, Al-Hajri F. n-Hospital and One-Year Clinical Outcome of Percutaneous Coronary Intervention in a Tertiary Hospital in Oman: Oman PCI Registry. Oman Medical Journal. 2017;32 (1):54-61. https://doi.org/10.5001/omj.2017.10

11. Alhabib KF, Kinsara AJ, Alghamdi S, Al-Murayeh M, Hussein GA, AlSaif S et al. The first survey of the Saudi Acute Myocardial Infarction Registry Program: Main results and long-term outcomes (STARS-1 Program). PLOS ONE. 2019;14 (5):e0216551. https://doi.org/10.1371/journal.pone.0216551

12. Minushkina L.O., Brazhnik V.A., Averkova A.O., Rogozhina A.A., Evdokimova M.A., Korolyova O.S. et al. Acute coronary syndrome in patients with diabetes mellitus: unified data of multicenter observational trials ORACLE I and ORACLE II. Therapy. 2019;5 (1):68-80.